featured
BLOOD 2021: The Presence of Cancer-Related Gene Mutations or Philadelphia Chromosome - Associated Events Confers Inferior Outcomes in CML
The link holds true despite switching tyrosine kinase inhibitor proactively and a higher starting dose of imatinib.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.